What are the differences between influenza A and influenza B?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differences Between Influenza A and Influenza B

Influenza A and B are distinct virus types that both cause epidemic human disease, but influenza A has pandemic potential due to its ability to undergo major genetic shifts and infect multiple animal species, while influenza B is restricted to humans and evolves more slowly.

Structural and Classification Differences

Influenza A Characteristics

  • Influenza A viruses are categorized into subtypes based on two surface antigens: hemagglutinin (H) and neuraminidase (N), with 16 H subtypes and 9 N subtypes identified in nature 1, 2
  • Currently, H1N1 and H3N2 subtypes circulate in humans and cause seasonal epidemics 1, 2
  • Influenza A has a broad host range including humans, birds, pigs, horses, and other mammals, making it a true zoonotic agent 3, 4

Influenza B Characteristics

  • Influenza B viruses are NOT categorized into subtypes but are separated into two distinct genetic lineages: Yamagata and Victoria 1, 2
  • Influenza B is restricted to humans with no significant animal reservoir, eliminating pandemic potential 3, 4
  • Both lineages co-circulate during most influenza seasons 1

Evolutionary and Genetic Differences

Rate of Antigenic Change

  • Influenza A undergoes antigenic drift MORE RAPIDLY than influenza B, resulting from frequent point mutations during viral replication 1, 2
  • Influenza B evolves more slowly and undergoes antigenic drift at a reduced rate compared to influenza A 1

Pandemic Potential

  • Only influenza A can cause pandemics through "antigenic shift" - major genetic reassortment between different viral strains, particularly when human and avian viruses exchange genetic material 1, 3
  • The 2009 H1N1 pandemic exemplifies this capability, where a novel virus emerged with limited pre-existing human immunity 1
  • Influenza B cannot cause pandemics due to its restriction to humans and lack of animal reservoirs for genetic reassortment 3

Genetic Incompatibility

  • Influenza A and B viruses cannot naturally reassort genetic segments with each other due to incompatible viral packaging signals required for segment incorporation into virions 5
  • This packaging signal incompatibility contributes to the evolutionary divergence and speciation of these two virus types 5

Clinical and Epidemiological Similarities

Disease Presentation

  • Both influenza A and B cause clinically indistinguishable illness characterized by abrupt onset of fever, myalgia, headache, malaise, nonproductive cough, sore throat, and rhinitis 1, 2
  • In children, both types commonly cause otitis media, nausea, and vomiting 1
  • Influenza A and B show similar pathogenic potential in humans and co-circulate during seasonal epidemics 1

Transmission and Infectious Period

  • Both types spread primarily through respiratory droplets from coughing and sneezing 1, 2, 6
  • The incubation period is identical: 1-4 days with an average of 2 days 1, 2, 6
  • Adults are infectious from the day before symptoms through approximately 5 days after illness onset for both types 1, 2, 6

Immunity and Cross-Protection

  • Antibody against one influenza virus type confers limited or NO protection against the other type 1, 6
  • Even within the same type, antibody to one antigenic variant may not protect against a new variant of the same subtype or lineage 1, 6
  • This lack of cross-protection necessitates annual vaccine updates to match circulating strains 2, 6

Clinical Pitfalls

  • Respiratory illness caused by influenza A versus B cannot be distinguished based on symptoms alone - laboratory confirmation is required for definitive diagnosis 1
  • The slower evolution of influenza B does not make it less clinically significant - it still accounts for approximately 25% of the annual influenza disease burden 7
  • Vaccine formulation must account for both influenza A subtypes (H1N1 and H3N2) and at least one influenza B lineage, though mismatch between circulating and vaccine B lineages has occurred in 5 of 10 seasons historically 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Influenza Virus Types and Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The pathogenesis of influenza in humans.

Reviews in medical virology, 2001

Research

Influenza viruses in animal wildlife populations.

Current topics in microbiology and immunology, 2007

Guideline

Influenza Virus Characteristics and Transmission

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the differences between influenza A and influenza B?
Which of the following statements about influenza are true: a) only influenza types A and B exist; b) the transmission period is from one day before symptom onset up to several days after; c) the clinical picture includes fever, headache, myalgia, cough, and sore throat; d) clinical symptoms include fever, headache, cough, vomiting, and diarrhea; e) the vaccine provides lifelong immunity?
What is the difference between Influenza A (Flu A) and Influenza B (Flu B)?
What are the key differences in managing Flu A (Influenza A) vs Flu B (Influenza B) in a broad patient demographic, including pediatric, adult, and geriatric populations with possible underlying health conditions?
What is the most appropriate pharmacologic weight‑loss agent for an adult patient currently taking lamotrigine 200 mg twice daily, propranolol 10 mg daily, buspirone 10 mg twice daily as needed, amphetamine/dextroamphetamine XR 30 mg each morning, amphetamine/dextroamphetamine 20 mg each evening, cariprazine 4.5 mg daily, and eszopiclone 3 mg at bedtime?
What are the adverse effects of glucagon-like peptide‑2 (GLP‑2) therapy, specifically teduglutide, in patients with short‑bowel syndrome?
Which syphilis screening test should be ordered first?
Why does hydroxychloroquine (HCQ) require ophthalmologic monitoring to prevent retinopathy?
How quickly does blood pressure rise after abruptly stopping olmesartan, and is tapering required to avoid rebound hypertension?
What is the most likely diagnosis and appropriate genetic testing for a 23‑year‑old male with autosomal‑recessive retinitis pigmentosa, mild‑to‑moderate intellectual disability, aggressive behavior, normal brain MRI, no other systemic anomalies, and similarly affected siblings?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.